Anavex Life Sciences Names Terrie Kellmeyer President and CEO

PUBT · 2d ago
Anavex Life Sciences Names Terrie Kellmeyer President and CEO
  • Anavex Life Sciences appointed Terrie Kellmeyer president and CEO effective Nov. 1, 2026.
  • Kellmeyer will also join the board. She previously served as interim CEO and senior vice president of clinical development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anavex Life Sciences Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611030700PRIMZONEFULLFEED9868638) on November 03, 2026, and is solely responsible for the information contained therein.